Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-π and telomerase in the early diagnosis of esophageal carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 39, 2005, Pages 6090-6095

  Zhu, Xuan ^a   Zhang, Shuang Hong ^a   Zhang, Kun He ^a   Li, Bi Ming ^a   Chen, Jiang ^a  

^a JIANGXI MEDICAL COLLEGE   (China)

Author keywords

Endoscopy; Esophageal carcinoma; Glutathione; S transferases; Telomerase

Indexed keywords

GLUTATHIONE TRANSFERASE; LUGOL; METHYLENE BLUE; TELOMERASE;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOENDOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DYSPLASIA; EARLY DIAGNOSIS; ENZYME ACTIVITY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRECANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SILVER STAINING; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 30644477212     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i39.6090     Document Type: Article

References (24)

1. Coles B, Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 1990; 25: 47-70
2. Colgin LM, Reddel RR. Telomerase maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev 1999; 9: 97-103
3. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol 2000; 18: 2626-2634
4. Qiu SL, Yang GR. Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer 1988; 62: 551-557
5. Canto MI. Methylene blue-directed biopsies improve detection of intestinal metaplasis and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000; 51: 560-568
6. Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, Lewin KJ, Roth MJ, Tio TL, Taylor PR. Mucosal lodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998; 83: 220-230
7. Sato K, Kitahara A, Sathoh Kl. The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Jpn J Cancer Res 1984; 75: 199-202
8. Ishioka C, Kanamaru R, Shibata H, Konishi Y, Ishikawa. A, Wakui A, Sato T, Nishihira T. Expression of glutathione S-transferase-π messenger RNA in human esophageal cancers. Cancer 1991; 67: 2560-2564
9. Li Z, Zhang R, Luo X. Expression of glutatgione S-transferase-π in human esophageal squamous cell carcinoma. Chin J Oncol 2001; 23: 39-42
10. Van SB, Lang TD. Control of telomere length by the human telomeric protein TRF1. Nature 1997; 385: 740-743
11. Grieder CW. Telomerase activation: one step on the road to cancer? Trends Genetics 1999; 13: 109-112
12. Chiu CP, Harley CB. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med 1997; 214: 99-106
13. Suzuki S, Fukushima T, Ami H, Onogi H, Nakamura I, Takenoshita S. New attempt of preoperative differential diagnosis of thyroid neoplasms by telomerase activity measurement. Oncol Rep 2002; 9: 539-544
14. Shah NG, Choksi TJ, Patel DD, Vora HH, Ghosh N, Trivedi TI, Trivedi KA. Telomerase activity in breast cancer in Western India (Gujarat). Int J Biol Markers 2002; 17: 49-55
15. Tominaga T, Kashimura H, Suzuki K, Nakahara A, Tanaka N, Noguchi M, Itabashi M, Ohkawa J. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues. J Gastroenterol 2002; 37: 418-427
16. Suzuki K, Kashimura H, Ohkawa J, Itabashi M, Watanabe T, Sawahata T, Nakahara A, Muto H, Tanaka N. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J Gastroenterol Hepatol 2000; 15: 744-751
17. Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma. Cancer 2003; 98: 1008-1013
18. Zhou JH, Zhang HM, Chen Q, Han DD, Pei F, Zhang LS, Yang DT. Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma. World J Gastroenterol 2003; 9: 1808-1814
19. Miura N, Shiota G, Nakagawa T, Maeda Y, Sano A, Marumoto A, Kishimoto Y, Murawaki Y, Hasegawa J. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Oncology 2003; 64: 430-434
20. Abe N, Watanabe T, Nakashima M, Masaki T, Mori T, Sugiyama M, Atomi Y. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma. Hepatogastroenterology 2001; 48: 692-695
21. Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 2000; 4: 135-142
22. Li C, Liang Y, Wu M, Xu L, Cai W. Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay. Chin Med J 2002; 115: 1405-1408
23. Koyanagi K, Ozawa S, Ando N, Mukai M, Kitagawa Y, Ueda M, Kitajima M. Telomerase activity as an indicator of malignant potential in iodine-nonreactive Lesions of the esophagus. Cancer 2000; 88: 1524-1529
24. Inai M, Kano M, Shimada Y, Sakurai T, Chiba T, Imamura M. Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis. Br J Cancer 2001; 85: 1006-1013